EUVIMEDEUVIMED entdecken
Crossref

Quality versus queasy: neurokinin 1 receptor antagonist use in moderately emetogenic chemotherapy

Jayan Nair, Brendan Curley, Richard Fong, Jimmy Hwang, Michael Byrne

The Journal of Community and Supportive Oncology · 2016

DOI: 10.12788/j.sder.0274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Community and Supportive Oncology, 2016. Verfasst von Jayan Nair und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Nair, J., Curley, B., Fong, R., Hwang, J., & Byrne, M. (2016). Quality versus queasy: neurokinin 1 receptor antagonist use in moderately emetogenic chemotherapy. The Journal of Community and Supportive Oncology. https://doi.org/10.12788/j.sder.0274

Vancouver

Nair J, Curley B, Fong R, Hwang J, Byrne M. Quality versus queasy: neurokinin 1 receptor antagonist use in moderately emetogenic chemotherapy. The Journal of Community and Supportive Oncology. 2016. doi:10.12788/j.sder.0274

BibTeX
@article{Nair2016,
  author = {Nair, Jayan and Curley, Brendan and Fong, Richard and Hwang, Jimmy and Byrne, Michael},
  title = {Quality versus queasy: neurokinin 1 receptor antagonist use in moderately emetogenic chemotherapy},
  journal = {The Journal of Community and Supportive Oncology},
  year = {2016},
  doi = {10.12788/j.sder.0274}
}
Kostenlos starten →